The region q13-15 of chromosome 12 frequently is altered in human sarcomas,
and several genes, such as SAS, CDK4, and MDM2, have been found to be ampl
ified in bone and soft tissue sarcomas, These genes and their products were
studied by quantitative polymerase chain reaction and immunohistochemical
analysis in 25 parosteal osteosarcoma samples (22 Grades I or II, three ded
ifferentiated) to evaluate if the possible alterations detected of the gene
s on chromosome 12 could have a role in the development of this rare bone t
umor. Immunohistochemical analysis was performed on formalin fixed, paraffi
n embedded tumor sections to evaluate CDK4 and MDM2 protein expression. To
measure the degree of SAS and CDK4 gene amplification, quantitative polymer
ase chain reaction was done on deoxyribonucleic acid derived from the same
samples. The results showed that CDK4 protein was expressed in 92% of the c
ases. Strong and uniform CDK4 and MDM2 immunoreactivity was found respectiv
ely in three of three and two of three dedifferentiated parosteal osteosarc
omas, SAS and CDK4 genes were found to be amplified fourfold in two Grade I
I tumors and in one dedifferentiated tumor. These findings, which should be
investigated further, might suggest a possible role of the chromosome 12 g
enes in the pathogenesis of parosteal osteosarcoma.